Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Neuropsychiatric Disease and Treatment|September 22, 2022
Provider Perspectives on the Current Use of Lithium Medications and Lithium Monitoring Practices for Psychiatric ConditionsGeorgia M Parkin, Elizabeth A Thomas
Journal of Psychiatric Research|February 18, 2020
Excitatory amino acid transporter (EAAT)1 and EAAT2 mRNA levels are altered in the prefrontal cortex of subjects with schizophreniaGeorgia M Parkin, Andrew Gibbons, Madhara Udawela, et al.
Ebiomedicine|June 14, 2023
Plasma NfL as a prognostic biomarker for enriching HD-ISS stage 1 categorisation: a cross-sectional studyGeorgia M Parkin, Elizabeth A Thomas, Jody Corey-Bloom
World Journal of Psychiatry|July 11, 2018
Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disordersGeorgia M Parkin, Madhara Udawela, Andrew Gibbons, et al.
Electrophoresis|October 28, 2018
Β-actin does not show the characteristics of a reference protein in human cortexGeorgia M Parkin, Madhara Udawela, Andrew Gibbons, et al.
Journal of Human Genetics|September 16, 2018
Catechol-O-methyltransferase (COMT) genotypes are associated with varying soluble, but not membrane-bound COMT protein in the human prefrontal cortexGeorgia M Parkin, Madhara Udawela, Andrew Gibbons, et al.
Journal of Neurology|January 23, 2025
Comparisons of neurodegenerative disease biomarkers across different biological fluids from patients with Huntington's diseaseAlison R Bamford, Georgia M Parkin, Jody Corey-Bloom, et al.
Clinical Parkinsonism & Related Disorders|March 1, 2024
Exploring bradyphrenia in Huntington's disease using the computerized test of information processing (CTiP)Georgia M Parkin, Braden Culbert, Emma Churchill, et al.
Pageof 3